Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Necroptosis of infiltrated macrophages drives Yersinia pestis dispersal within buboes.

Arifuzzaman M, Ang WXG, Choi HW, Nilles ML, St John AL, Abraham SN.

JCI Insight. 2018 Sep 20;3(18). pii: 122188. doi: 10.1172/jci.insight.122188. [Epub ahead of print]

2.

What Goes Up Must Come Down: Integrating Air and Water Quality Monitoring for Nutrients.

Amos HM, Miniat CF, Lynch J, Compton J, Templer PH, Sprague LA, Shaw D, Burns D, Rea A, Whitall D, Myles L, Gay D, Nilles M, Walker J, Rose AK, Bales J, Deacon J, Pouyat R.

Environ Sci Technol. 2018 Oct 8. doi: 10.1021/acs.est.8b03504. [Epub ahead of print]

PMID:
30230820
3.

[Dermoscopically conspiciuous pigmented lesion on the forehead of a young male patient].

Menzer C, Stolz W, Nilles M, Toberer F, Fink C, Haenssle HA.

Hautarzt. 2017 Dec;68(12):1028-1030. doi: 10.1007/s00105-017-4059-4. German. No abstract available.

PMID:
28983642
4.

Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement.

Fink AL, Williams KL, Harris E, Alvine TD, Henderson T, Schiltz J, Nilles ML, Bradley DS.

PLoS Negl Trop Dis. 2017 Jul 7;11(7):e0005721. doi: 10.1371/journal.pntd.0005721. eCollection 2017 Jul.

5.
6.

Identification of the Targets of Type III Secretion System Inhibitors.

Condry DL, Nilles ML.

Methods Mol Biol. 2017;1531:203-211.

PMID:
27837494
8.

Expression and Purification of N-Terminally His-Tagged Recombinant Type III Secretion Proteins.

Alvine TD, Osei-Owusu P, Condry DL, Nilles ML.

Methods Mol Biol. 2017;1531:183-191.

PMID:
27837492
10.

Analysis of Type III Secretion System Secreted Proteins.

Condry DL, Nilles ML.

Methods Mol Biol. 2017;1531:93-99.

PMID:
27837484
11.

Isolation of Type III Secretion System Needle Complexes by Shearing.

Nilles ML, Condry DL, Osei-Owusu P.

Methods Mol Biol. 2017;1531:61-70.

PMID:
27837481
12.
13.

Blue Native Protein Electrophoresis to Study the T3S System Using Yersinia pestis as a Model.

Henderson TA, Nilles ML.

Methods Mol Biol. 2017;1531:33-46.

PMID:
27837479
14.

Introduction to Type III Secretion Systems.

Condry DL, Nilles ML.

Methods Mol Biol. 2017;1531:1-10. Review.

PMID:
27837477
15.

The onset of electron-induced proton-transfer in hydrated azabenzene cluster anions.

Wang Y, Zhang X, Lyapustina S, Nilles MM, Xu S, Graham JD, Bowen KH, Kelly JT, Tschumper GS, Hammer NI.

Phys Chem Chem Phys. 2016 Jan 14;18(2):704-12. doi: 10.1039/c5cp02746b.

PMID:
26327590
16.

[77-year-old female with hyponatremia, pruritus and papulous exanthema].

Brock J, Karrasch T, Roller FC, Steiner D, Nilles M, Blau W, Gattenlöhner S, Schäffler A.

Dtsch Med Wochenschr. 2015 Jun;140(13):997-1000. doi: 10.1055/s-0041-102667. Epub 2015 Jun 26. German. Erratum in: Dtsch Med Wochenschr. 2015 Jul;140(15):1118. Roller, Ferdinand Fritz [corrected to Roller, Fritz Christian].

PMID:
26115135
17.

Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure.

Haese N, Brocato RL, Henderson T, Nilles ML, Kwilas SA, Josleyn MD, Hammerbeck CD, Schiltz J, Royals M, Ballantyne J, Hooper JW, Bradley DS.

PLoS Negl Trop Dis. 2015 Jun 5;9(6):e0003803. doi: 10.1371/journal.pntd.0003803. eCollection 2015.

18.

The N terminus of type III secretion needle protein YscF from Yersinia pestis functions to modulate innate immune responses.

Osei-Owusu P, Jessen Condry DL, Toosky M, Roughead W, Bradley DS, Nilles ML.

Infect Immun. 2015 Apr;83(4):1507-22. doi: 10.1128/IAI.02687-14. Epub 2015 Feb 2.

19.

Effects of urbanization on mercury deposition and accumulation in New England.

Chalmers AT, Krabbenhoft DP, Van Metre PC, Nilles MA.

Environ Pollut. 2014 Sep;192:104-12. doi: 10.1016/j.envpol.2014.05.003. Epub 2014 Jun 6.

PMID:
24907856
20.

Type III secretion needle proteins induce cell signaling and cytokine secretion via Toll-like receptors.

Jessen DL, Osei-Owusu P, Toosky M, Roughead W, Bradley DS, Nilles ML.

Infect Immun. 2014 Jun;82(6):2300-9. doi: 10.1128/IAI.01705-14. Epub 2014 Mar 18.

21.

A type III secretion system inhibitor targets YopD while revealing differential regulation of secretion in calcium-blind mutants of Yersinia pestis.

Jessen DL, Bradley DS, Nilles ML.

Antimicrob Agents Chemother. 2014;58(2):839-50. doi: 10.1128/AAC.01170-13. Epub 2013 Nov 18.

22.

Wet deposition of fission-product isotopes to North America from the Fukushima Dai-ichi incident, March 2011.

Wetherbee GA, Gay DA, Debey TM, Lehmann CM, Nilles MA.

Environ Sci Technol. 2012 Mar 6;46(5):2574-82. doi: 10.1021/es203217u. Epub 2012 Feb 22.

PMID:
22356354
23.

Resistance to Yersinia pestis infection decreases with age in B10.T(6R) mice.

Lambert ND, Langfitt DM, Nilles ML, Bradley DS.

Infect Immun. 2011 Nov;79(11):4438-46. doi: 10.1128/IAI.05267-11. Epub 2011 Aug 22.

24.

[A 39-year-old patient with maculopapular rash, recurrent fever, and arthralgia].

Freund V, Budihardja D, Nilles M, Mayser P.

Hautarzt. 2009 Jul;60(7):578-82. doi: 10.1007/s00105-009-1738-9. German.

PMID:
19543861
25.

The novel protein PTPIP51 is expressed in human keratinocyte carcinomas and their surrounding stroma.

Koch P, Stenzinger A, Viard M, Märker D, Mayser P, Nilles M, Schreiner D, Steger K, Wimmer M.

J Cell Mol Med. 2008 Oct;12(5B):2083-95. doi: 10.1111/j.1582-4934.2008.00198.x.

26.

Reduced expression of nicotinic alpha subunits 3, 7, 9 and 10 in lesional and nonlesional atopic dermatitis skin but enhanced expression of alpha subunits 3 and 5 in mast cells.

Kindt F, Wiegand S, Niemeier V, Kupfer J, Löser C, Nilles M, Kurzen H, Kummer W, Gieler U, Haberberger RV.

Br J Dermatol. 2008 Sep;159(4):847-57. doi: 10.1111/j.1365-2133.2008.08774.x. Epub 2008 Jul 30.

PMID:
18671783
27.

LcrG secretion is not required for blocking of Yops secretion in Yersinia pestis.

Reina LD, O'Bryant DM, Matson JS, Nilles ML.

BMC Microbiol. 2008 Feb 8;8:29. doi: 10.1186/1471-2180-8-29.

28.

Resistance of Yersinia pestis to complement-dependent killing is mediated by the Ail outer membrane protein.

Bartra SS, Styer KL, O'Bryant DM, Nilles ML, Hinnebusch BJ, Aballay A, Plano GV.

Infect Immun. 2008 Feb;76(2):612-22. Epub 2007 Nov 19.

29.

Roles of YopN, LcrG and LcrV in controlling Yops secretion by Yersinia pestis.

Hamad MA, Nilles ML.

Adv Exp Med Biol. 2007;603:225-34. Review.

PMID:
17966419
30.

Structure-function analysis of the C-terminal domain of LcrV from Yersinia pestis.

Hamad MA, Nilles ML.

J Bacteriol. 2007 Sep;189(18):6734-9. Epub 2007 Jul 20.

31.

[Solitary blue nodule on the ear helix].

Akkash L, Nilles M, Mayser P.

Hautarzt. 2008 Jan;59(1):54-7. Review. German. No abstract available.

PMID:
17565480
32.

Intermedin: a skin peptide that is downregulated in atopic dermatitis.

Kindt F, Wiegand S, Löser C, Nilles M, Niemeier V, Hsu SY, Steinhoff M, Kummer W, Gieler U, Haberberger RV.

J Invest Dermatol. 2007 Mar;127(3):605-13. Epub 2006 Sep 28.

33.

[Malassezia yeasts and their significance in dermatology].

Hort W, Nilles M, Mayser P.

Hautarzt. 2006 Jul;57(7):633-43; quiz 644-5. Review. German.

PMID:
16758222
34.

Treatment of head and neck dermatitis with ciclopiroxolamine cream--results of a double-blind, placebo-controlled study.

Mayser P, Kupfer J, Nemetz D, Schäfer U, Nilles M, Hort W, Gieler U.

Skin Pharmacol Physiol. 2006;19(3):153-8. Epub 2006 Apr 6.

PMID:
16612143
35.

Immunization of mice with YscF provides protection from Yersinia pestis infections.

Matson JS, Durick KA, Bradley DS, Nilles ML.

BMC Microbiol. 2005 Jun 24;5:38.

36.

The value of immunohistochemistry in atypical cutaneous fibrous histiocytoma.

Wilk M, Zelger BG, Nilles M, Zelger B.

Am J Dermatopathol. 2004 Oct;26(5):367-71.

PMID:
15365367
37.

Dissecting the structure of LcrV from Yersinia pestis, a truly unique virulence protein.

Nilles ML.

Structure. 2004 Mar;12(3):357-8. No abstract available.

38.
39.

Case report. Cutaneous phaeohyphomycosis due to Alternaria alternata.

Mayser P, Nilles M, de Hoog GS.

Mycoses. 2002 Oct;45(8):338-40.

PMID:
12572725
40.

Genome sequence of Yersinia pestis KIM.

Deng W, Burland V, Plunkett G 3rd, Boutin A, Mayhew GF, Liss P, Perna NT, Rose DJ, Mau B, Zhou S, Schwartz DC, Fetherston JD, Lindler LE, Brubaker RR, Plano GV, Straley SC, McDonough KA, Nilles ML, Matson JS, Blattner FR, Perry RD.

J Bacteriol. 2002 Aug;184(16):4601-11.

41.

Interaction of the Yersinia pestis type III regulatory proteins LcrG and LcrV occurs at a hydrophobic interface.

Matson JS, Nilles ML.

BMC Microbiol. 2002 Jun 28;2:16. Erratum in: BMC Microbiol. 2002 Sep 5;2(1):25..

42.
43.

Virulence role of V antigen of Yersinia pestis at the bacterial surface.

Fields KA, Nilles ML, Cowan C, Straley SC.

Infect Immun. 1999 Oct;67(10):5395-408.

44.
45.

The MtrD protein of Neisseria gonorrhoeae is a member of the resistance/nodulation/division protein family constituting part of an efflux system.

Hagman KE, Lucas CE, Balthazar JT, Snyder L, Nilles M, Judd RC, Shafer WM.

Microbiology. 1997 Jul;143 ( Pt 7):2117-25.

PMID:
9245801
46.
47.

[Epithelioid cell histiocytoma].

Wilk M, Schmoeckel C, Nilles M, Krahl D, Eckert F, Kreysel HW.

Hautarzt. 1996 Jul;47(7):526-9. German.

PMID:
8926168
48.

[Solitary subcutaneous metastasis of a chondrosarcoma].

Malek B, Thomas M, Nilles M, Schill WB.

Hautarzt. 1994 Oct;45(10):722-4. German.

PMID:
8002343
49.

Surface microscopy of naevi and melanomas--clues to melanoma.

Nilles M, Boedeker RH, Schill WB.

Br J Dermatol. 1994 Mar;130(3):349-55.

PMID:
8148277
50.

Elastosis and cancer.

Lohmann W, Schill WB, Bucher D, Peters T, Nilles M, Schulz A, Bohle R.

Z Naturforsch C. 1994 Mar-Apr;49(3-4):223-9.

PMID:
8018252

Supplemental Content

Loading ...
Support Center